Innate Pharma is a biopharmaceutical company that develops immunotherapy drug candidates for the treatment of cancer and inflammatory diseases. The company focuses on the development of new therapeutic solutions and monoclonal antibodies aimed at improving patient outcomes in the oncology sector.

Services include:
- Development of immunotherapy drug candidates
- Research and development of monoclonal antibodies
- Therapeutic solutions for cancer treatment
- Solutions for inflammatory disease treatments

Innate Pharma is committed to advancing innovative therapies and improving healthcare outcomes in the pharmaceutical industry. For more information, please visit innate-pharma.com.